EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antiviral Activity of (1S,9aR)-1-[(1,2,3-Triazol-1-yl)methyl]octahydro-1H-quinolizines from the Alkaloid Lupinine

Zhangeldy S Nurmaganbetov iD, Oralgazy A Nurkenov iD, Andrei I Khlebnikov iD, Serik D Fazylov iD, Roza B Seidakhmetova, Zhanar K Tukhmetova, Altynaray T Takibayeva iD, Gaukhar Khabdolda, Zhanar B Rakhimberlinova iD, Aigul K Kaldybayeva iD, Elvira E Shults iD

Molecules · 05.12.2024 · 29 (23) · 5742

DOI: 10.3390/molecules29235742 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 05.12.2024. Verfasst von Zhangeldy S Nurmaganbetov und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Synthesis of Biologically Active Substances, Institute of Organic Synthesis and Coal Chemistry, Karaganda 100008, Kazakhstan. Hauptthemen laut MEDLINE: Antiviral Agents, Molecular Docking Simulation, Alkaloids. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Ministry of Science and Education of the Republic of Kazakhstan, Ministry of Science and Education of the Republic of Kazakhstan, Tomsk Polytechnic University Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Influenza is a disease of significant morbidity and mortality. The number of anti-influenza drugs is small; many of them stimulate the appearance of resistant strains. This article presents the results of assessing the antiviral activity of 1,2,3-triazole-containing derivatives of alkaloid lupinine for their ability to suppress the reproduction of orthomyxoviruses (influenza viruses: A/Vladivostok/2/09 (H1N1) and A/Almaty/8/98 (H3N2)). The ability of (1S,9aR)-1-[(1,2,3-triazol-1-yl)-methyl]octahydro-1H-quinolizines with aryl-, 4-((4-formylphenoxy)methyl)- or 4-((3-tert-butyl-5-ethyl-2-hydroxy-benzoyloxy)methyl)- substituents at the C-4 position of the triazole ring to reduce the infectivity of the virus when processing virus-containing material was established, indicating good prospects for the studied compounds as virucidal agents affecting extracellular virions. The experimental results demonstrated that the triazolyl lupinine derivatives exhibited varying degrees of affinity for both hemagglutinin and neuraminidase proteins. Furthermore, these compounds demonstrated inhibitory effects on the replication of influenza viruses with different antigenic subtypes. The obtained biological data are in agreement with the results of molecular docking, which showed strong binding energies of the investigated compounds under study with biological targets—hemagglutinin and neuraminidase proteins. Following the evaluation of antiviral efficacy among the studied triazolyl derivatives of lupinine, four compounds have been identified for subsequent comprehensive in vitro and in vivo investigations to further elucidate their antiviral properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsMolecular Docking SimulationAlkaloidsAnimalsInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeDogsHumansTriazolesMadin Darby Canine Kidney CellsVirus ReplicationQuinolizidines

Stichwörter der Autor:innen

(1S,9aR)-1-[(1,2,3-triazol-1-yl)methyl]octahydro-1H-quinolizinesTamiflualkaloid lupinineantiviral activitymolecular dockingorthomyxovirusesrimantadine

Substanzen

Antiviral AgentsAlkaloidsTriazolesQuinolizidines

Autor:innen und Institutionen

  • Laboratory of Synthesis of Biologically Active Substances, Institute of Organic Synthesis and Coal Chemistry, Karaganda 100008, Kazakhstan.
  • School of Pharmacy, Karaganda Medical University, Karaganda 100008, Kazakhstan.
  • Kizhner Research Center, Tomsk Polytechnic University, 634050 Tomsk, Russia.
  • Department of Clinical Pharmacology and Evidence-Based Medicine, Karaganda Medical University, Karaganda 100008, Kazakhstan.
  • Department of Biomedicine, Karaganda Medical University, Karaganda 100008, Kazakhstan.
  • Department of Chemistry and Chemical Technology, A. Saginov Karaganda Technical University, Karaganda 100027, Kazakhstan.

ORCID-Profile: Zhangeldy S Nurmaganbetov, Oralgazy A Nurkenov, Andrei I Khlebnikov, Serik D Fazylov, Altynaray T Takibayeva, Zhanar B Rakhimberlinova, Aigul K Kaldybayeva, Elvira E Shults

Förderung

  • the Ministry of Science and Education of the Republic of Kazakhstan
  • Ministry of Science and Education of the Republic of Kazakhstan
  • Tomsk Polytechnic University Development Program

Zitieren

APA

Nurmaganbetov, Z. S., Nurkenov, O. A., Khlebnikov, A. I., Fazylov, S. D., Seidakhmetova, R. B., Tukhmetova, Z. K., Takibayeva, A. T., Khabdolda, G., Rakhimberlinova, Z. B., Kaldybayeva, A. K., & Shults, E. E. (2024). Antiviral Activity of (1S,9aR)-1-[(1,2,3-Triazol-1-yl)methyl]octahydro-1H-quinolizines from the Alkaloid Lupinine. Molecules, 29(23), 5742. https://doi.org/10.3390/molecules29235742

Vancouver

Nurmaganbetov ZS, Nurkenov OA, Khlebnikov AI, Fazylov SD, Seidakhmetova RB, Tukhmetova ZK, et al. Antiviral Activity of (1S,9aR)-1-[(1,2,3-Triazol-1-yl)methyl]octahydro-1H-quinolizines from the Alkaloid Lupinine. Molecules. 2024;29(23):5742. doi:10.3390/molecules29235742

BibTeX
@article{Nurmaganbetov2024,
  author = {Nurmaganbetov, Zhangeldy S and Nurkenov, Oralgazy A and Khlebnikov, Andrei I and Fazylov, Serik D and Seidakhmetova, Roza B and Tukhmetova, Zhanar K and Takibayeva, Altynaray T and Khabdolda, Gaukhar and Rakhimberlinova, Zhanar B and Kaldybayeva, Aigul K and Shults, Elvira E},
  title = {Antiviral Activity of (1S,9aR)-1-[(1,2,3-Triazol-1-yl)methyl]octahydro-1H-quinolizines from the Alkaloid Lupinine},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {23},
  pages = {5742},
  doi = {10.3390/molecules29235742}
}
Kostenlos starten →